News Center

位置：

Honors Announcement

Group News

Media Reports

Uniting Hearts and Pooling Strength to Usher in a New Journey: Striding Forward with Determination—Shijiazhuang Sihua Pharmaceutical Group Holds Marketing Recognition Conference

Category:

Group News

发布时间：2026-02-25

【概要描述】 Diligence brings spring early; now is the time to forge ahead. On the seventh day of the first lunar month, Shijiazhuang No. 4 Pharmaceutical Group solemnly convened a marketing awards ceremony at the Hutuo Hotel. With the theme “The Horse Springs into a New Journey: Pooling Strength to Tackle Tough Challenges and Ushering in a New Era of High-Quality Marketing Development Through Pragmatic Action,” the event sounded the rallying call for the year’s marketing efforts, galvanizing the entire marketing team into a mighty force determined to strive for excellence. Leaders of the Group—including Su Xuejun, Wu Hengyao, Shi Jianhui, Meng Guo, Zhang Guozhen, Wang Chunfa, Sun Lijie, Tian Pengmei, and Qu Benyue—attended the meeting, which was chaired by Li Xiaoyang.

Uniting Hearts and Pooling Strength to Usher in a New Journey: Striding Forward with Determination—Shijiazhuang Sihua Pharmaceutical Group Holds Marketing Recognition Conference

Diligence brings spring early; now is the time to forge ahead. On the seventh day of the first lunar month, Shijiazhuang No. 4 Pharmaceutical Group solemnly convened a marketing awards ceremony at the Hutuo Hotel. With the theme “A New Journey for the Horse—Pooling Strength to Tackle Tough Challenges and Ushering in a New Era of High-Quality Marketing Development Through Pragmatic Action,” the event sounded the rallying call for the year’s marketing efforts, rallying the entire marketing team into a mighty force determined to strive for excellence. Attending the meeting were group leaders Su Xuejun, Wu Hengyao, Shi Jianhui, Meng Guo, Zhang Guozhen, Wang Chunfa, Sun Lijie, Tian Pengmei, Qu Benyue, and others, with Li Xiaoyang serving as the chair of the ceremony.

At the outset of the conference, Zhang Guozhen, Group Executive President and General Manager of the Pharmaceutical Business Unit, delivered the opening address. He squarely addressed the industry’s transformation and market challenges, outlined the core objectives for marketing in 2026, and urged all marketing personnel to adopt a “start with a decisive battle and sprint from the very beginning” mindset—rising to meet difficulties head-on, striving with unwavering determination, and making every effort to seize market opportunities and deliver outstanding results.

Subsequently, the conference held a centralized awards ceremony to recognize outstanding collectives and individuals who made exceptional contributions over the past year in terminal development, product promotion, and market enhancement. Group leaders presented certificates of honor and cash prizes to the winners one by one, amid thunderous applause that vividly showcased the spirited and dynamic image of the Four-Pharmaceuticals marketing team.

The outstanding representatives honored have been deeply rooted in the front lines of the market, diligently honing their skills and fearlessly overcoming challenges, thereby making remarkable contributions to expanding the Group’s market coverage and enhancing its brand influence. This recognition is not only the highest commendation for their hard work but also a heartfelt source of inspiration for all marketing professionals, injecting powerful spiritual momentum into the year ahead.

Amid warm applause, Chairman Su Xuejun of the Group delivered a speech that grounded itself in the overarching trends of the industry and closely aligned with the Group’s specific circumstances, clearly outlining the strategic direction with resolute and inspiring words.

He pointed out that the pharmaceutical industry is currently undergoing accelerating transformation and intense competition; clinging to traditional practices offers no way forward. Only by proactively embracing change and boldly innovating can we break new ground and seize emerging opportunities. As the “frontline bastion” of development, the marketing system must take the lead in championing this transformative agenda, driving all-round innovation and reinvention to firmly secure the initiative in our strategic development.

He emphasized the following five priorities: First, accurately grasp the policy direction of centralized drug procurement, squarely face challenges while seizing opportunities, use centralized procurement as a breakthrough to deepen engagement at the end-user level, leverage product strengths to upgrade and refine services, convert policy benefits into developmental advantages, and better support the Healthy China initiative. Second, establish seamless links among “innovation–translation–market,” accelerating the transformation of innovation-driven strengths into market advantages, ensuring that research outcomes and high-quality products enter the market, serve clinical practice, and become the core engine of high-quality development. Third, expedite the export of finished dosage forms and active pharmaceutical ingredients, capitalizing on product quality and international certification advantages to expand export volumes, deepen penetration in existing markets, explore emerging markets, and elevate export operations toward “brand-based exports” and “value-driven exports.” Building on the EU CEP certification already obtained for products such as caffeine, we will accelerate efforts to secure higher-level international certifications for finished dosage forms, enhance our global influence, and cultivate new growth drivers. Fourth, deepen the empowerment of “AI+,” leveraging our foundation in digital and intelligent transformation to integrate artificial intelligence across all marketing functions, build an intelligent management platform, and use digitalization to reshape marketing competitiveness, thereby improving quality, reducing costs, and boosting efficiency. Fifth, strengthen foundational management by forging a highly competent, professionally skilled, and exemplary marketing team—one that is resolute, battle-ready, and committed to success—while continuously optimizing management processes, refining operational measures, reinforcing performance-based evaluation and compliance-oriented business practices, rigorously managing accounts receivable, solidifying the foundation for healthy corporate development, and driving the Group toward sustainable, high-quality growth.

The conference boosted morale, inspired everyone to strive forward, and forged a powerful consensus on unity of purpose and unwavering determination. Attendees were deeply encouraged and pledged to translate the spirit of the conference into concrete actions, dedicating themselves to marketing with full enthusiasm and high fighting spirit, delivering outstanding results to repay the Group’s trust and expectations, and writing a glorious new chapter in the high-quality development of the Group and Shijiazhuang’s biopharmaceutical industry!

Following the awards ceremony, the Group hosted a grand reception to bid farewell and boost the morale of its marketing team as they prepare to head out into the field.

Keywords:

Students from the School of Chemical Engineering at Hebei University of Technology Visit Guangxiang Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group, for Observation and Study

Gathering Momentum and Energy to Usher in a New Journey—Shijiazhuang Sihua Pharmaceutical Group Holds Its “First Spring Training” for Marketing

Students from the School of Chemical Engineering at Hebei University of Technology Visit Guangxiang Pharmaceutical, Shijiazhuang Sihua Pharmaceutical Group, for Observation and Study

Gathering Momentum and Energy to Usher in a New Journey—Shijiazhuang Sihua Pharmaceutical Group Holds Its “First Spring Training” for Marketing